ekonominyheter

TranslateRSSMobil
This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success

Fool.com 12/11 10:43

Achillion Pharmaceuticals is working on an adjunct therapy that could significantly reduce the number of weeks hepatitis C patients would require treatment.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status